Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,527 across all filing types
Latest filing 2012-09-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
Monthly return of equity issuer on movements in securities for the month ended 31 August 2012
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/8/2012, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other agreements related to share issuance. The content focuses on changes in the company's capital structure and share movements during a specific month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements as required by the exchange, not a financial report or announcement of voting results. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other categories.
2012-09-03 English
FURTHER DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a further delay in the despatch of a circular related to an acquisition and an extraordinary general meeting (EGM). It references previous announcements and states a new expected date for sending the circular. The document is short (2029 characters) and serves as an update on the timing of a shareholder communication rather than the communication itself or a detailed report. It does not contain financial data, detailed report content, or regulatory certifications. This fits the profile of a Regulatory Filing (RNS) as a general regulatory announcement and update that does not fit other specific categories.
2012-08-24 English
2012 Interim results announcement
Interim / Quarterly Report Classification · 100% confidence The document is titled '2012 INTERIM RESULTS ANNOUNCEMENT' and contains detailed unaudited consolidated financial statements for the six months ended 30 June 2012, including income statement, statement of financial position, notes on accounting policies, segment information, taxation, dividends, earnings per share, and trade receivables/payables. It references compliance with Hong Kong Accounting Standard 34 'Interim Financial Reporting' and includes substantive financial data and analysis for the half-year period. The length of the document (15,000 characters) and the detailed financial content confirm it is a comprehensive interim financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2012
2012-08-15 English
Date of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a short announcement from China Pharmaceutical Group Limited stating the date of a board meeting to approve unaudited results for the six months ended 30 June 2012. It does not contain any financial data or detailed report content but merely informs about the upcoming board meeting. The length is only 1313 characters, which is quite short and fits the pattern of an announcement rather than a full interim or quarterly report. According to the rules, such announcements about board meetings to approve financial results are best classified as Regulatory Filings (RNS) because they do not contain substantive financial data or analysis themselves.
2012-08-03 English
Monthly return of equity issuer on movements in securities for the month ended 31 July 2012
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/7/2012, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance report rather than a financial report or announcement. The document length is substantial (14,874 characters), indicating it is a full report rather than a brief announcement. Given the nature of the content and the regulatory context, this fits best under 'Regulatory Filings' (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories like capital changes (SHA) or share transactions (POS) because it covers a broad range of share capital movements and related securities information in a monthly return format.
2012-08-03 English
DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding a delay in the despatch of a circular related to an acquisition and an extraordinary general meeting (EGM). It references a previous announcement and states that the circular, which includes details of the acquisition and notice of the EGM, will be postponed. The document is short (2039 characters) and serves as an update or notification rather than containing the actual circular or detailed financial information. Therefore, it is not the circular itself or a full report but an announcement about the timing of a report. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2012-07-17 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.